Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenbaum

Showing results (131-140 of 225) with videos related to

Pageof 23
Sort By:
Diabetologia|January 18, 2022
Characterising the age-dependent effects of risk factors on type 1 diabetes progressionMichelle So, Colin O'Rourke, Alyssa Ylescupidez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetesJunbao Yang, I-Ting Chow, Tomasz Sosinowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2018
DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 DiabetesEddie A James, Laurel Gillette, Ivana Durinovic-Bello, et al.
Diabetes Care|June 3, 2009
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Lisa Rafkin-Mervis, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1987
Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthmaH Eigen, J J Reid, R Dahl, et al.
JBMR Plus|September 30, 2020
Acute Hyperinsulinemia Alters Bone Turnover in Women and Men With Type 1 DiabetesVanessa D Sherk, Timothy Vigers, Laura Pyle, et al.
Diabetologia|September 1, 2018
Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetesSusanne M Cabrera, Samuel Engle, Mary Kaldunski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2023
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive IndividualsAlyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, et al.
Diabetes Care|January 14, 2010
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetesPeter A Gottlieb, Scott Quinlan, Heidi Krause-Steinrauf, et al.
Diabetes|August 5, 2010
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko, Jay S Skyler, Jeffrey P Krischer, et al.
Pageof 23

Showing results (131-140 of 225) with videos related to

Sort By:
Pageof 23
Diabetologia|January 18, 2022
Characterising the age-dependent effects of risk factors on type 1 diabetes progressionMichelle So, Colin O'Rourke, Alyssa Ylescupidez, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetesJunbao Yang, I-Ting Chow, Tomasz Sosinowski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 21, 2018
DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 DiabetesEddie A James, Laurel Gillette, Ivana Durinovic-Bello, et al.
Diabetes Care|June 3, 2009
Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1Jay M Sosenko, Jerry P Palmer, Lisa Rafkin-Mervis, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1987
Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthmaH Eigen, J J Reid, R Dahl, et al.
JBMR Plus|September 30, 2020
Acute Hyperinsulinemia Alters Bone Turnover in Women and Men With Type 1 DiabetesVanessa D Sherk, Timothy Vigers, Laura Pyle, et al.
Diabetologia|September 1, 2018
Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetesSusanne M Cabrera, Samuel Engle, Mary Kaldunski, et al.
The Journal of Clinical Endocrinology and Metabolism|August 12, 2023
OGTT Metrics Surpass Continuous Glucose Monitoring Data for T1D Prediction in Multiple-Autoantibody-Positive IndividualsAlyssa Ylescupidez, Cate Speake, Susan L Pietropaolo, et al.
Diabetes Care|January 14, 2010
Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetesPeter A Gottlieb, Scott Quinlan, Heidi Krause-Steinrauf, et al.
Diabetes|August 5, 2010
Glucose excursions between states of glycemia with progression to type 1 diabetes in the diabetes prevention trial-type 1 (DPT-1)Jay M Sosenko, Jay S Skyler, Jeffrey P Krischer, et al.
Pageof 23